scholarly journals Bridging cardiogenic shock patients with short-term ventricular support at a community hospital to long-term ventricular support at a tertiary hospital

2012 ◽  
Vol 31 (6) ◽  
pp. 618-624 ◽  
Author(s):  
José González-Costello ◽  
Jonathan Yang ◽  
Daniel B. Sims ◽  
Alexander P. Kossar ◽  
Lindsay K. Murray ◽  
...  
Keyword(s):  
Cardiogenic Shock ◽  
Community Hospital ◽  
Tertiary Hospital ◽  
Short Term ◽  
Ventricular Support

Cardiac Support Devices

2017 ◽  
Author(s):  
Charles C. Hill ◽  
Lindsay Raleigh
Keyword(s):  
Heart Failure ◽  
Cardiogenic Shock ◽  
Mechanical Circulatory Support ◽  
Life Support ◽  
Ventricular Assist Devices ◽  
Circulatory Support ◽  
Short Term ◽  
Assist Device ◽  
Ventricular Assist

Mechanical circulatory support (MCS) involves the use of intra-aortic balloon pump (IABP), short-term percutaneous ventricular assist devices, long-term surgically implanted continuous-flow ventricular assist devices (cf-LVADs), and extracorporeal membrane oxygenation (ECMO) for the treatment of acute and chronic heart failure and cardiogenic shock. IABP is increasingly recognized as an important adjunct in the postoperative treatment arsenal for those patients with severely reduced left ventricular systolic function. Short-term percutaneous options for the treatment of acute right and left heart failure include both the Impella and Tandem Heart, whereas the Centrimag is often used in the surgical setting for acute cardiogenic shock and heart failure. Long-term surgical MCS options include the total artificial heart and the cf-LVADs HeartWare and Heartmate II. ECMO is frequently used for the treatment of acute cardiogenic shock and may be placed peripherally via a percutaneous approach or with central cannulation. ECMO is also increasingly used in the setting of acute cardiac life support, known as extracorporeal life support. Key words: cardiac critical care, extracorporeal membrane oxygenation, long-term ventricular assist device, mechanical circulatory support, short-term ventricular assist device 

Attending to the Heartbeat in Dance Movement Psychotherapy

2017 ◽  
pp. 902-924
Author(s):  
Mariam Mchitarian ◽  
Jospeh A. Moutiris ◽  
Vicky Karkou
Keyword(s):  
Tertiary Hospital ◽  
Psychological Status ◽  
Therapeutic Tool ◽  
Short Term ◽  
Rehabilitation Centre ◽  
Dance Movement ◽  
Future Events ◽  
Term Benefit

Coronary heart disease (CHD) is a significant cause of morbidity and mortality worldwide. Interventions to reduce future events in patients with established CHD include, apart from medical and pharmaceutical means, a change in lifestyle, social, and psychological support, and other interventions such as dance movement psychotherapy (DMP). This chapter describes the potential usefulness of DMP as a therapeutic tool in acute and chronic cardiac patients. Data from two studies among CHD patients, conducted in a tertiary hospital and in a rehabilitation centre, are presented. Both of these studies show short-term benefit in the quality of life and psychological status of patients. Although methodological limitations did not allow for the establishment of long-term benefits of this intervention for CHD patients, this chapter hypothesizes that long-lasting benefits are possible.

Cardiac Support Devices

2017 ◽  
Author(s):  
Charles C. Hill ◽  
Lindsay Raleigh
Keyword(s):  
Heart Failure ◽  
Cardiogenic Shock ◽  
Mechanical Circulatory Support ◽  
Life Support ◽  
Ventricular Assist Devices ◽  
Circulatory Support ◽  
Short Term ◽  
Assist Device ◽  
Ventricular Assist

Mechanical circulatory support (MCS) involves the use of intra-aortic balloon pump (IABP), short-term percutaneous ventricular assist devices, long-term surgically implanted continuous-flow ventricular assist devices (cf-LVADs), and extracorporeal membrane oxygenation (ECMO) for the treatment of acute and chronic heart failure and cardiogenic shock. IABP is increasingly recognized as an important adjunct in the postoperative treatment arsenal for those patients with severely reduced left ventricular systolic function. Short-term percutaneous options for the treatment of acute right and left heart failure include both the Impella and Tandem Heart, whereas the Centrimag is often used in the surgical setting for acute cardiogenic shock and heart failure. Long-term surgical MCS options include the total artificial heart and the cf-LVADs HeartWare and Heartmate II. ECMO is frequently used for the treatment of acute cardiogenic shock and may be placed peripherally via a percutaneous approach or with central cannulation. ECMO is also increasingly used in the setting of acute cardiac life support, known as extracorporeal life support. Key words: cardiac critical care, extracorporeal membrane oxygenation, long-term ventricular assist device, mechanical circulatory support, short-term ventricular assist device 

scholarly journals Prognosis of Patients With Cardiogenic Shock Following Acute Myocardial Infarction: The Difference Between ST-Segment Elevation Myocardial Infarction And Non-ST-Segment Elevation Myocardial Infarction

2021 ◽  
Author(s):  
Ming-Lung Tsai ◽  
Ming-Jer Hsieh ◽  
Chun-Chi Chen ◽  
Victor Chien-Chia Wu ◽  
Wen-Ching Lan ◽  
...  
Keyword(s):  
Myocardial Infarction ◽  
Acute Myocardial Infarction ◽  
Cardiogenic Shock ◽  
Short Term ◽  
Bleeding Rate ◽  
St Segment Elevation ◽  
Segment Elevation Myocardial Infarction ◽  
St Segment ◽  
Short Term Mortality

Abstract Background: Acute myocardial infarction (AMI) complicated with cardiogenic shock has high mortality and is a challenging topic even in the revascularization era. We conducted this study to understand patients’ outcomes.Method: We retrospectively analyzed electronic medical records data from 1,175 patients with AMI complicated with cardiogenic shock developed within 3 days of admission to a multicenter medical care system between January 1, 2000, and July 31, 2018. AMI patients were classified into ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI) group. The short-term and 1-year mortality and adverse event after the index admission were analyzed via logistic regression and Cox proportional hazards model. Results: Comparing to NSTEMI, patients with STEMI tended to be younger (65.68 ± 14.05 vs. 70.70 ± 12.99, p < .001), men (73.29 vs. 60.87, p < .001), and have fewer underlying chronic diseases. Short-term mortality at index hospitalization was 14.83% in the STEMI group and 21.30% in the NSTEMI group; long-term mortality was 17.06% for the STEMI group and 24.13% for the NSTEMI group. No difference was observed between the 2 groups for patients who developed a cerebral vascular accident (CVA) during the admission period; however, the major bleeding rate and gastrointestinal bleeding rate were higher in the STEMI group (2.66 vs. 0.22, p = .014; 3.36 vs. 0.22, p = .007, respectively). Conclusion: In patients with AMI with cardiogenic shock, NSTEMI was associated with a significantly higher mortality rate in both the short-and long-term results. Age and respiratory failure were the most significant risk factors for short-term mortality. Revascularization may be beneficial for the short-term outcome but did not reach significance in multivariable analysis.

Cardiac Support Devices

2018 ◽  
Author(s):  
Charles C. Hill ◽  
Lindsay Raleigh
Keyword(s):  
Heart Failure ◽  
Cardiogenic Shock ◽  
Mechanical Circulatory Support ◽  
Life Support ◽  
Ventricular Assist Devices ◽  
Circulatory Support ◽  
Short Term ◽  
Assist Device ◽  
Ventricular Assist

Mechanical circulatory support (MCS) involves the use of intra-aortic balloon pump (IABP), short-term percutaneous ventricular assist devices, long-term surgically implanted continuous-flow ventricular assist devices (cf-LVADs), and extracorporeal membrane oxygenation (ECMO) for the treatment of acute and chronic heart failure and cardiogenic shock. IABP is increasingly recognized as an important adjunct in the postoperative treatment arsenal for those patients with severely reduced left ventricular systolic function. Short-term percutaneous options for the treatment of acute right and left heart failure include both the Impella and Tandem Heart, whereas the Centrimag is often used in the surgical setting for acute cardiogenic shock and heart failure. Long-term surgical MCS options include the total artificial heart and the cf-LVADs HeartWare and Heartmate II. ECMO is frequently used for the treatment of acute cardiogenic shock and may be placed peripherally via a percutaneous approach or with central cannulation. ECMO is also increasingly used in the setting of acute cardiac life support, known as extracorporeal life support. Key words: cardiac critical care, extracorporeal membrane oxygenation, long-term ventricular assist device, mechanical circulatory support, short-term ventricular assist device 

Sign in / Sign up

Export Citation Format

Share Document